14-10-2026 08:26 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Board Meetings
Medplus Health Services Ltd.
 
Source DateBoard Meeting DateDetails
28-Sep-2026 27-Oct-2026 Quarterly Results
07-Jul-2026 21-Jul-2026 Quarterly Results
04-May-2026 20-May-2026 Audited Results (Revised) & Quarterly Results
30-Mar-2026 29-May-2026 Quarterly Results & Audited Results
05-Jan-2026 30-Jan-2026 Quarterly Results
01-Oct-2025 31-Oct-2025 Quarterly Results
10-Jul-2025 02-Aug-2025 Quarterly Results
25-Mar-2025 27-May-2025 Audited Results
08-Jan-2025 31-Jan-2025 Quarterly Results
10-Oct-2024 12-Nov-2024 Quarterly Results
27-Jun-2024 02-Aug-2024 Quarterly Results
01-Apr-2024 28-May-2024 Audited Results
16-Feb-2024 21-Feb-2024 Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023.
27-Dec-2023 02-Feb-2024 Quarterly Results
25-Oct-2023 08-Nov-2023 Quarterly Results (Revised)
18-Oct-2023 26-Oct-2023 Quarterly Results
06-Oct-2023 11-Oct-2023 Inter alia, to consider and evaluate proposal for raising of funds by the Company, by way of inter alio, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alio, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. The Board, would further convene an Extra-ordinary General Meeting or postal ballot to obtain the approval of shareholders for the above proposal, once approved by the Board.
03-Oct-2023 05-Oct-2023 Inter alia, to consider and approve the Proposal for raising of funds by the Company
10-Jul-2023 07-Aug-2023 Quarterly Results (Revised)
07-Jul-2023 01-Aug-2023 Quarterly Results
Page 1 of 2
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code | Research Analyst Certificate | Internal policy RA
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.